Live Breaking News & Updates on Casdin capital

Stay informed with the latest breaking news from Casdin capital on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Casdin capital and stay connected to the pulse of your community

Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics

Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Philadelphia , Pennsylvania , Brent-pfeiffenberger , Julie-seidel-noor , Exchange-commission , Bain-capital-life-sciences , Capital-management , Nasdaq , Lazard , Clade-therapeutics-inc , Goodwin-procter

Century Therapeutics (IPSC) to Acquire Clade Therapeutics, Announces $60M Private Placement

Century Therapeutics (IPSC) to Acquire Clade Therapeutics, Announces $60M Private Placement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Julie-seidel-noor , Brent-pfeiffenberger , Goodwin-procter , Lazard , Bain-capital-life-sciences , Nasdaq , Exchange-commission , Clade-therapeutics-inc , Capital-management , Century-therapeutics , Clade-therapeutics

Earli Detection: "Synthetic" Biomarkers Light Up Hidden Malignant Cancers

Earli Detection: "Synthetic" Biomarkers Light Up Hidden Malignant Cancers
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Stanford , California , United-states , Stanford-university , Redwood-city , Milan , Lombardia , Italy , Bob-langer , Sangeeta-bhatia , Lee-hartwell , R-martin-chavez

Insider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) Insider Sells $70,600.00 in Stock

Insider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) Insider Sells $70,600.00 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Sarah-aebersold , Blackrock-inc , Biolife-solutions , News-ratings-for-biolife-solutions-daily , Biolife-solutions-stock-performance , Jefferies-financial-group , Institutional-trading-of-biolife-solutions , Goldman-sachs-group-inc , Biolife-solutions-inc , Vanguard-group-inc , Millennium-management

2seventy bio, Inc. (NASDAQ:TSVT) Director Casdin Capital, Llc Purchases 300,000 Shares

2seventy bio, Inc. (NASDAQ:TSVT) Director Casdin Capital, Llc Purchases 300,000 Shares
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada , United-states , Leerink-partnrs , Royal-bank , Nasdaq , Securities-exchange-commission , Group-plc , Principal-financial-group-inc , Life-insurance-co , Casdin-capital-llc , Get-free-report , Director-casdin-capital

Casdin Capital, Llc Purchases 330,000 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) Stock

2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) Director Casdin Capital, Llc bought 330,000 shares of the stock in a transaction dated Monday, March 25th. The shares were acquired at an average price of $5.07 per share, for a total transaction of $1,673,100.00. Following the completion of the purchase, the director now directly owns 1,960,000 […]

Canada , United-states , Leerink-partnrs , Casdin-capital-llc , Group-plc , Life-insurance-co , Royal-bank , Principal-financial-group-inc , Nasdaq , Get-free-report , Director-casdin-capital , Casdin-capital

Casdin Capital, Llc Acquires 330,000 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) Stock

2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) Director Casdin Capital, Llc purchased 330,000 shares of the business’s stock in a transaction dated Monday, March 25th. The shares were purchased at an average cost of $5.07 per share, for a total transaction of $1,673,100.00. Following the completion of the purchase, the director now directly owns […]

United-states , Leerink-partnrs , Zurcher-kantonalbank-zurich-cantonalbank , Us-bancorp , Nasdaq , Group-one-trading , Company-profile , Ameritas-investment-partners-inc , Life-insurance-co , Casdin-capital-llc , Get-free-report , Director-casdin-capital

Chardan Capital Reaffirms "Buy" Rating for Tenaya Therapeutics (NASDAQ:TNYA)

Chardan Capital reaffirmed their buy rating on shares of Tenaya Therapeutics (NASDAQ:TNYA – Free Report) in a research report report published on Thursday morning, Benzinga reports. Chardan Capital currently has a $20.00 price objective on the stock. TNYA has been the subject of several other reports. Canaccord Genuity Group decreased their price objective on Tenaya […]

United-states , Leerink-partnrs , Timothy-hoey , Group-gp-lp-column , Casdin-capital , Securities-exchange-commission , Pricet-rowe-associates-inc , Blackrock-inc , Canaccord-genuity-group , Tenaya-therapeutics-inc , Chardan-capital , Tenaya-therapeutics